{"id":"https://openalex.org/W4361908561","doi":"https://doi.org/10.1158/1078-0432.22451288.v1","title":"Supplementary Table 1 from Phase I Study of Aurora A Kinase Inhibitor MLN8237 in Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics, and Bioavailability of Two Oral Formulations","display_name":"Supplementary Table 1 from Phase I Study of Aurora A Kinase Inhibitor MLN8237 in Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics, and Bioavailability of Two Oral Formulations","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361908561","doi":"https://doi.org/10.1158/1078-0432.22451288.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22451288.v1","doi":"https://doi.org/10.1158/1078-0432.22451288.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451288.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Phase_I_Study_of_Aurora_A_Kinase_Inhibitor_MLN8237_in_Advanced_Solid_Tumors_Safety_Pharmacokinetics_Pharmacodynamics_and_Bioavailability_of_Two_Oral_Formulations/22451288/1/files/39902369.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Phase_I_Study_of_Aurora_A_Kinase_Inhibitor_MLN8237_in_Advanced_Solid_Tumors_Safety_Pharmacokinetics_Pharmacodynamics_and_Bioavailability_of_Two_Oral_Formulations/22451288/1/files/39902369.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063734850","display_name":"E. Claire Dees","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Claire Dees","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110382646","display_name":"Roger B. Cohen","orcid":"https://orcid.org/0009-0004-7423-2653","observed_orcids":["https://orcid.org/0009-0004-7423-2653"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roger B. Cohen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085336500","display_name":"Margaret von Mehren","orcid":"https://orcid.org/0000-0001-6158-890X","observed_orcids":["https://orcid.org/0000-0001-6158-890X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaret von Mehren","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014554706","display_name":"Thomas E. Stinchcombe","orcid":"https://orcid.org/0000-0002-3595-8011","observed_orcids":["https://orcid.org/0000-0002-3595-8011"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas E. Stinchcombe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100321336","display_name":"Hua Liu","orcid":"https://orcid.org/0000-0003-2798-3337","observed_orcids":["https://orcid.org/0000-0003-2798-3337","https://orcid.org/0009-0007-8715-2988"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hua Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044490765","display_name":"Karthik Venkatakrishnan","orcid":"https://orcid.org/0000-0003-4039-9813","observed_orcids":["https://orcid.org/0000-0003-4039-9813"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karthik Venkatakrishnan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009817418","display_name":"Mark G Manfredi","orcid":"https://orcid.org/0000-0002-5920-8784","observed_orcids":["https://orcid.org/0000-0002-5920-8784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Manfredi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069781389","display_name":"Howard J. Fingert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Howard Fingert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072308451","display_name":"Howard A. Burris","orcid":"https://orcid.org/0000-0002-1501-2931","observed_orcids":["https://orcid.org/0000-0002-1501-2931"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Howard A. Burris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103514741","display_name":"Jeffrey R. Infante","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey R. Infante","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.013100000098347664,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mln8237","display_name":"MLN8237","score":0.9950000047683716},{"id":"https://openalex.org/keywords/aurora-a-kinase-inhibitor","display_name":"Aurora A kinase inhibitor","score":0.7059999704360962},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7450000047683716},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.8199999928474426},{"id":"https://openalex.org/keywords/oral-formulations","display_name":"oral dosage forms","score":0.5889999866485596},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9039999842643738},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5220000147819519},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8820266723632812},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7570017576217651},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.7410998344421387},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7169586420059204},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5683367252349854},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.553378701210022}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22451288.v1","doi":"https://doi.org/10.1158/1078-0432.22451288.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451288.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Phase_I_Study_of_Aurora_A_Kinase_Inhibitor_MLN8237_in_Advanced_Solid_Tumors_Safety_Pharmacokinetics_Pharmacodynamics_and_Bioavailability_of_Two_Oral_Formulations/22451288/1/files/39902369.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22451288","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Phase_I_Study_of_Aurora_A_Kinase_Inhibitor_MLN8237_in_Advanced_Solid_Tumors_Safety_Pharmacokinetics_Pharmacodynamics_and_Bioavailability_of_Two_Oral_Formulations/22451288","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22451288.v1","doi":"https://doi.org/10.1158/1078-0432.22451288.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451288.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Phase_I_Study_of_Aurora_A_Kinase_Inhibitor_MLN8237_in_Advanced_Solid_Tumors_Safety_Pharmacokinetics_Pharmacodynamics_and_Bioavailability_of_Two_Oral_Formulations/22451288/1/files/39902369.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.550000011920929,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361908561.pdf","grobid_xml":"https://content.openalex.org/works/W4361908561.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2046280088","https://openalex.org/W1505739641","https://openalex.org/W2254638634","https://openalex.org/W2369345461","https://openalex.org/W4364376666","https://openalex.org/W2141289501","https://openalex.org/W2960553615","https://openalex.org/W3043458966","https://openalex.org/W2162491061","https://openalex.org/W2307066354"],"abstract_inverted_index":{"PDF":[0],"file,":[1],"59K,":[2],"Summary":[3],"of":[4],"pharmacokinetic":[5],"parameters":[6],"for":[7],"MLN8237":[8],"PIC":[9],"formulation":[10],"after":[11],"multiple":[12],"dose":[13],"oral":[14],"administration":[15],"dosing":[16],"in":[17],"the":[18],"7-,":[19],"14-,":[20],"and":[21],"21-day":[22],"schedules.":[23]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}